CD274 and neoplasm: The immune status of lymph nodes is an important factor in predicting the efficacy of ICIs, and lymph nodes with tumor metastasis often show significant immunosuppression, such as immune escape and increased PD-L1 expression, which are associated with worse response to neoadjuvant immunotherapy and shorter disease-free survival.